MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/07853890.2026.2700794

Медицинская библиотека · Annals of medicine · 2026

Effects of intraoperative low-dose remimazolam maintenance on emergence agitation and emergence time in patients undergoing oral surgery: protocol for a randomized controlled trial.

Hu Xiaoxuan, Fu Chong, Bi Guorong, Tan Qiyun, Ying Yaoyu, Zhao Weiming, Cai Xuechun, Yin Nan, Wang Xin, Liu Hong, Meng Lingzhong, Ji Fu-Hai, Sun Qiang, Zhao Baojian, Liu Huayue

Протокол клинического исследованияСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

Emergence agitation (EA) is a clinically significant complication during early recovery from general anesthesia. This protocol describes a randomized controlled trial designed to determine whether intraoperative low-dose remimazolam maintenance reduces the incidence of EA without prolonging emergence time in patients undergoing oral surgery.

PATIENTS AND

METHODS

This multicenter, randomized, controlled clinical trial will enroll 388 patients scheduled for oral surgery under general anesthesia. Patients will be randomly allocated in a 1:1 ratio to either the remimazolam group, receiving a low-dose intraoperative infusion of remimazolam, or the control group, receiving an equivalent volume of normal saline. The primary outcome is the incidence of emergence agitation; the key secondary outcome is emergence time. Emergence time will be evaluated within a non-inferiority framework, whereas the incidence of emergence agitation will be tested for superiority. Additional endpoints comprise pain scores, analgesic use, the rate of postoperative nausea and vomiting (PONV), recourse to rescue antiemetics, the occurrence of postoperative sleep disturbance (PSD), time spent in the post-anesthesia care unit (PACU), postoperative hospital length of stay, overall recovery quality, the frequency of perioperative adverse events, and patient satisfaction.

DISCUSSION: This trial will investigate the efficacy and safety of intraoperative low-dose remimazolam maintenance in patients undergoing oral surgery. The findings may provide evidence supporting a practical pharmacological intervention to reduce EA and enhance postoperative recovery.

TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR2600116544).

Для цитирования: Hu Xiaoxuan, Fu Chong, Bi Guorong, Tan Qiyun, Ying Yaoyu, Zhao Weiming, Cai Xuechun, Yin Nan, Wang Xin, Liu Hong, Meng Lingzhong, Ji Fu-Hai, Sun Qiang, Zhao Baojian, Liu Huayue. Effects of intraoperative low-dose remimazolam maintenance on emergence agitation and emergence time in patients undergoing oral surgery: protocol for a randomized controlled trial.. Annals of medicine. 2026. DOI: 10.1080/07853890.2026.2700794.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.